News

March 28, 2007 - With an estimated 70 million Americans currently living with cardiovascular disease, the demand for services in the catheterization ("cath") lab continues to escalate. In fact, an estimated 4.21 million patient cases were performed at 1,970 cardiac cath lab sites in 2006, representing a 9 percent increase from 3.85 million in 2002.

Home March 27, 2007
Home
Technology

Toshiba America Medical Systems Inc. announced the introduction of its Infinix VF-i/SP X-ray system, a universal cardiovascular system designed to accommodate diagnostic and interventional procedures. The system will be showcased at the American College of Cardiology (ACC) annual meeting in New Orleans March 24-27, 2007.

Home March 27, 2007
Home
Technology

The Xper Information Management is Philips’ new personalized cardiovascular workflow solution. The product suite presents a variety of new innovations for reporting, image review, scheduling, inventory and intelligent data management. With tools that enhance efficiency on multiple levels, the solution improves and simplifies workflow for all cardiovascular professionals.

Home March 27, 2007
Home
Technology

Agfa HealthCare's Scheduling for Cardiology solution, a Web-enabled scheduling solution for resources management within cardiovascular departments, has been designed to be configurable to multiple, personal-based workflows. Scheduling for Cardiology’s Web-based architecture provides viewing and management of resource availability from any point of access to the hospital network.

Home March 27, 2007
Home
Technology

In an effort to continue the successful launch of the s5i integrated IVUS system in the US and Europe, Volcano has ...

Home March 27, 2007
Home
Technology

Siemens introduced the AXIOM Sensis XP - a new generation of integrated recording solutions that increases procedural efficiency, allowing for optimal patient care in the cath lab.

Home March 27, 2007
Home
Technology

Siemens Medical Solutions previewed a hand-held ultrasound unit, the Acuson P10, intended primarily for triage and screening applications in acute care settings. In the future, personal imaging tools such as this could improve the standard of care for inpatient monitoring, critical care, outpatient specialty visits and bedside exams.

Home March 27, 2007
Home
Technology

ScImage announced that it is delivering a fully customizable reporting and workflow documentation solution for vascular procedures. The reporting solution will be offered as an add-on to the company’s award winning Enterprise PACS solution, PicomEnterprise.

Home March 27, 2007
Home
Technology

The results of Boston Scientific's pivotal SPIRIT III clinical trial reaffirmed prior safety and efficacy data for the market-leading TAXUS Express2 Paclitaxel-Eluting Coronary Stent System and provided early positive data for the XIENCE V (PROMUS) Everolimus-Eluting Coronary Stent System.

Home March 27, 2007
Home
Technology

As the pioneer of metabolic assessment and behavioral therapy technologies, BodyMedia is developing tools that empower health professionals to better treat patients with chronic health conditions such as obesity, diabetes and cardiovascular disease (CVD).

Home March 27, 2007
Home
Technology

Data released from the bridge-to-transplantation (BTT) arm of the HeartMate II Pivotal trial demonstrate that the device provides effective mechanical circulatory support as a bridge to transplantation for heart failure patients, and that these patients experience a lower number of adverse events and an improved quality of life while being supported by the device.

Home March 27, 2007
Home
Technology

ZOLL Medical Corp. has received FDA clearance to market and sell the ZOLL M Series with Real CPR Help technology. The device enables rescuers to instantly see and hear how well they are performing the rate and depth of CPR chest compressions. The M Series is the Company’s best-selling product to date. The approval extends Real CPR Help to ZOLL’s complete defibrillator product line.

Home March 26, 2007
Home
News

Boston Scientific Corp. announced two-year results from the TAXUS V In-Stent Restenosis (ISR) trial, demonstrating that the TAXUS Express2 paclitaxel-eluting coronary stent system met its primary endpoint in the treatment of in-stent restenosis - the regrowth of diseased tissue into a previously stented artery utilizing bare-metal stents - compared to vascular brachytherapy.

Home March 25, 2007
Home
Technology

VIASYS Healthcare is showcasing the launch of the MasterScreen CPX, a product that combines 40 years of CPET experience into a compact unit.

Home March 22, 2007
Home
Technology

Pfizer says the FDA has approved the company’s Lipitor (atorvastatin calcium) Tablets to reduce the risk of nonfatal heart attacks, fatal and non-fatal strokes, certain types of heart surgery, hospitalization for heart failure, and chest pain in patients with heart disease — making Lipitor the first cholesterol-lowering medication to receive FDA approval for the reduction of the risk of hospit

Home March 22, 2007
Home
Subscribe Now